Your browser doesn't support javascript.
loading
The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants.
Thompson, Corinne N; Le, Thi Phuong Tu; Anders, Katherine L; Nguyen, Trong Hieu; Lu, Lan Vi; Nguyen, Van Vinh Chau; Vu, Thuy Duong; Nguyen, Ngoc Minh Chau; Tran, Thi Hong Chau; Ha, Thanh Tuyen; Tran, Vu Thieu Nga; Pham, Van Minh; Tran, Do Hoang Nhu; Le, Thi Quynh Nhi; Saul, Allan; Martin, Laura B; Podda, Audino; Gerke, Christiane; Thwaites, Guy; Simmons, Cameron P; Baker, Stephen.
Afiliación
  • Thompson CN; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK; London School of Hygiene and Tropical Medicine, London, UK.
  • Le TP; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Anders KL; School of Biological Sciences, Monash University, Victoria, Australia.
  • Nguyen TH; Hung Vuong Hospital, Ho Chi Minh City, Viet Nam.
  • Lu LV; The Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
  • Nguyen VV; The Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
  • Vu TD; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Nguyen NM; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Tran TH; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Ha TT; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Tran VT; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Pham VM; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Tran do HN; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Le TQ; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Saul A; Novartis Vaccines Institute for Global Health(2), A GSK Company, Siena, Italy.
  • Martin LB; Novartis Vaccines Institute for Global Health(2), A GSK Company, Siena, Italy.
  • Podda A; Novartis Vaccines Institute for Global Health(2), A GSK Company, Siena, Italy.
  • Gerke C; Novartis Vaccines Institute for Global Health(2), A GSK Company, Siena, Italy.
  • Thwaites G; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK.
  • Simmons CP; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK; Department of Microbiology and Immunology, University of Melbourne, Australia.
  • Baker S; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK; London School of Hygiene and Tropical Medicine, London, UK. Electronic address: sbaker
Vaccine ; 34(6): 783-90, 2016 Feb 03.
Article en En | MEDLINE | ID: mdl-26742945
ABSTRACT

BACKGROUND:

Shigella sonnei is an emergent and major diarrheal pathogen for which there is currently no vaccine. We aimed to quantify duration of maternal antibody against S. sonnei and investigate transplacental IgG transfer in a birth cohort in southern Vietnam. METHODS AND

RESULTS:

Over 500-paired maternal/infant plasma samples were evaluated for presence of anti-S. sonnei-O IgG and IgM. Longitudinal plasma samples allowed for the estimation of the median half-life of maternal anti-S. sonnei-O IgG, which was 43 days (95% confidence interval 41-45 days). Additionally, half of infants lacked a detectable titer by 19 weeks of age. Lower cord titers were associated with greater increases in S. sonnei IgG over the first year of life, and the incidence of S. sonnei seroconversion was estimated to be 4/100 infant years. Maternal IgG titer, the ratio of antibody transfer, the season of birth and gestational age were significantly associated with cord titer.

CONCLUSIONS:

Maternal anti-S. sonnei-O IgG is efficiently transferred across the placenta and anti-S. sonnei-O maternal IgG declines rapidly after birth and is undetectable after 5 months in the majority of children. Preterm neonates and children born to mothers with low IgG titers have lower cord titers and therefore may be at greater risk of seroconversion in infancy.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Shigella sonnei / Inmunoglobulina G / Inmunidad Materno-Adquirida / Anticuerpos Antibacterianos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male / Newborn País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Shigella sonnei / Inmunoglobulina G / Inmunidad Materno-Adquirida / Anticuerpos Antibacterianos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male / Newborn País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido
...